1% Lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors

Archives of Surgery

Volumn 139, Issue 11, 2004, Pages 1180-1184

  Dan, Adrian G ^a   Saha, Sukamal ^a,b   Monson, Keith M ^a   Wiese, David ^a   Schocket, Elie ^a   Barber, Kimberly R ^a   Ganatra, Balvant ^a   Desai, Delip ^a   Kaushal, Sunil ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; FLUORESCEIN; HEMATOXYLIN; ISOSULFAN BLUE; TRACER;

CANCER STAGING; CARCINOMA IN SITU; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; OCCULT CANCER; PREDICTION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; ULTRAVIOLET RADIATION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORESCEIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 7744241809     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.11.1180     Document Type: Review

References (30)

1. Bilchik AJ, Giuliano A, Essner R, et al. Universal application of intraoperative lymphatic mapping and lymphadenectomy in solid neoplasms. Cancer J Sci Am. 1998; 4:351-358.
2. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multi-center trial. Ann Surg. 1999;230:453-465.
3. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941-946.
4. Saha S, Nora D, Wong J, Weise D. Sentinel lymph node mapping in colorectal cancer: a review. Surg Clin North Am. 2000;80:1811-1819.
5. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel protocol C-03. J Clin Oncol. 1993;11:1879-1887.
6. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer [review]. Curr Probl Surg. 1997;34:601-676.
7. Cabanas R. An approach to the treatment of penile carcinoma. Cancer. 1977;39:456-466.
8. Morton DL, Wen DR, Wong HH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
9. Pickren JW. Significance of occult metastases: a study of breast cancer. Cancer. 1961;14:1266-1271.
10. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999;23:263-267.
11. Haboubi NY, Clark P, Kaftan SM, Schofield PF. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med. 1992;85:386-388.
12. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin E Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:563-569.
13. Mori M, Mimori K, Ueo H, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by RT-PCR reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998;16:128-132.
14. Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokeratin-20 RT-PCR reaction in lymph nodes of node-negative colorectel cancer patients. J Clin Oncol. 2002;20:1049-1055.
15. Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectel cancer and its impact on staging. Ann Surg Oncol. 2000;7:120-124.
16. Tsioulias G, Wood T, Morton D, et al. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg. 2000; 135:926-932.
17. Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectel cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol. 2001;8:150-157.
18. Bilchik A, Nora D, Tollenaar R, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer. 2002;38:977-985.
19. Wong J, Steineman S, Calderia C, et al. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg. 2001;233:515-521.
20. Paramo J, Summerall J, Poppiti R, et al. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol. 2002;9:550-554.
21. Bendavid Y, Latulippe J, Younan R, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol. 2002;79:81-84.
22. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm. 1985;4:219-221.
23. Leong S, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7:361-366.
24. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery. 2001;129:119-120.
25. Kopp W. Anaphylaxis from alphazurine 2G during lymphography [case report]. JAMA. 1966;198:668-669.
26. Coleman R, Whitten C, O'Boyle J, Sidhu B. Unexplained decrease in measured oxygen saturation by pulse oxymetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol. 1999;70:126-129.
27. Larsen VH, Freudendal-Pedersen A, Fogh-Andersen N. The influence of patent blue V on pulse oximetry and haemoximetry. Acta Anaesthesiol Scand Suppl. 1995;107:53-55.
28. Kessler M, Eide T, Humayun B, Poppers P. Spurious pulse oxymetry desaturation with methylene blue injection. Anesthesiology. 1986;65:435-436.
29. Scheller M, Unger R, Keiner M. Effects of intravenously administered dyes on pulse oxymetry readings. Anesthesiology. 1986;65:550-552.
30. Saha S, Dan A, Berman B, et al. Lymphazurin 1% vs. technetium sulfur colloid for lymphatic mapping in colorectal tumors: a comparative analysis. Ann Surg Oncol. 2004;11:21-26.